

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding lipodystrophy: a... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-1756/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-1756" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.">
            <meta name="og:description" content="Read the latest article version by Thiago Bruder-Nascimento, Taylor C. Kress, Eric J. Belin de Chantemele, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="22135">
            <meta name="article-id" content="20150">
            <meta name="dc.title" content="Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function">
            <meta name="dc.description" content="Lipodystrophy is a disease characterized by a partial or total absence of adipose tissue leading to severe metabolic derangements including marked insulin resistance, type 2 diabetes, hypertriglyceridemia, and steatohepatitis. Lipodystrophy is also a source of major cardiovascular disorders which, in addition to hepatic failure and infection, contribute to a significant reduction in life expectancy. Metreleptin, the synthetic analog of the adipocyte-derived hormone leptin and current therapy of choice for patients with lipodystrophy, successfully improves metabolic function. However, while leptin has been associated with hypertension, vascular diseases, and inflammation in the context of obesity, it remains unknown whether its daily administration could further impair cardiovascular function in patients with lipodystrophy. The goal of this short review is to describe the cardiovascular phenotype of patients with lipodystrophy, speculate on the etiology of the disorders, and discuss how the use of murine models of lipodystrophy could be beneficial to address the question of the contribution of leptin to lipodystrophy-associated cardiovascular disease.">
            <meta name="dc.subject" content="lipodystrophy, cardiovascular disease, metreleptin, cardiomyopathy, hypertension  ">
            <meta name="dc.creator" content="Bruder-Nascimento, Thiago">
            <meta name="dc.creator" content="Kress, Taylor C.">
            <meta name="dc.creator" content="Belin de Chantemele, Eric J.">
            <meta name="dc.date" content="2019/10/16">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.20150.1">
            <meta name="dc.source" content="F1000Research 2019 8:1756">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="lipodystrophy">
            <meta name="prism.keyword" content="cardiovascular disease">
            <meta name="prism.keyword" content="metreleptin">
            <meta name="prism.keyword" content="cardiomyopathy">
            <meta name="prism.keyword" content="hypertension  ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/10/16">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="1756">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.20150.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-1756">
            <meta name="citation_title" content="Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function">
            <meta name="citation_abstract" content="Lipodystrophy is a disease characterized by a partial or total absence of adipose tissue leading to severe metabolic derangements including marked insulin resistance, type 2 diabetes, hypertriglyceridemia, and steatohepatitis. Lipodystrophy is also a source of major cardiovascular disorders which, in addition to hepatic failure and infection, contribute to a significant reduction in life expectancy. Metreleptin, the synthetic analog of the adipocyte-derived hormone leptin and current therapy of choice for patients with lipodystrophy, successfully improves metabolic function. However, while leptin has been associated with hypertension, vascular diseases, and inflammation in the context of obesity, it remains unknown whether its daily administration could further impair cardiovascular function in patients with lipodystrophy. The goal of this short review is to describe the cardiovascular phenotype of patients with lipodystrophy, speculate on the etiology of the disorders, and discuss how the use of murine models of lipodystrophy could be beneficial to address the question of the contribution of leptin to lipodystrophy-associated cardiovascular disease.">
            <meta name="citation_description" content="Lipodystrophy is a disease characterized by a partial or total absence of adipose tissue leading to severe metabolic derangements including marked insulin resistance, type 2 diabetes, hypertriglyceridemia, and steatohepatitis. Lipodystrophy is also a source of major cardiovascular disorders which, in addition to hepatic failure and infection, contribute to a significant reduction in life expectancy. Metreleptin, the synthetic analog of the adipocyte-derived hormone leptin and current therapy of choice for patients with lipodystrophy, successfully improves metabolic function. However, while leptin has been associated with hypertension, vascular diseases, and inflammation in the context of obesity, it remains unknown whether its daily administration could further impair cardiovascular function in patients with lipodystrophy. The goal of this short review is to describe the cardiovascular phenotype of patients with lipodystrophy, speculate on the etiology of the disorders, and discuss how the use of murine models of lipodystrophy could be beneficial to address the question of the contribution of leptin to lipodystrophy-associated cardiovascular disease.">
            <meta name="citation_keywords" content="lipodystrophy, cardiovascular disease, metreleptin, cardiomyopathy, hypertension  ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Thiago Bruder-Nascimento">
            <meta name="citation_author_institution" content="Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USA">
            <meta name="citation_author_institution" content="Department of Pediatrics, Division of Endocrinology, University of Pittsburgh, Pittsburgh, PA, USA">
            <meta name="citation_author" content="Taylor C. Kress">
            <meta name="citation_author_institution" content="Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USA">
            <meta name="citation_author" content="Eric J. Belin de Chantemele">
            <meta name="citation_author_institution" content="Department of Medicine, Section of Cardiology, Medical College of Georgia at Augusta University, Augusta, GA, USA">
            <meta name="citation_author_institution" content="Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USA">
            <meta name="citation_publication_date" content="2019/10/16">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="1756">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.20150.1">
            <meta name="citation_firstpage" content="1756">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-1756/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-1756.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=22135 /> <input type=hidden id=articleId name=articleId value=20150 /> <input type=hidden id=xmlUrl value="/articles/8-1756/v1/xml"/> <input type=hidden id=xmlFileName value="-8-1756-v1.xml"> <input type=hidden id=article_uuid value=fcda0961-7e39-40e3-80ca-6ac8c2c2e96f /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.20150.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.20150.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-1756"
  },
  "headline": "Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and...",
  "datePublished": "2019-10-16T10:32:28",
  "dateModified": "2019-10-16T10:32:28",
  "author": [
    {
      "@type": "Person",
      "name": "Thiago Bruder-Nascimento"
    },    {
      "@type": "Person",
      "name": "Taylor C. Kress"
    },    {
      "@type": "Person",
      "name": "Eric J. Belin de Chantemele"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Lipodystrophy is a disease characterized by a partial or total absence of adipose tissue leading to severe metabolic derangements including marked insulin resistance, type 2 diabetes, hypertriglyceridemia, and steatohepatitis. Lipodystrophy is also a source of major cardiovascular disorders which, in addition to hepatic failure and infection, contribute to a significant reduction in life expectancy. Metreleptin, the synthetic analog of the adipocyte-derived hormone leptin and current therapy of choice for patients with lipodystrophy, successfully improves metabolic function. However, while leptin has been associated with hypertension, vascular diseases, and inflammation in the context of obesity, it remains unknown whether its daily administration could further impair cardiovascular function in patients with lipodystrophy. The goal of this short review is to describe the cardiovascular phenotype of patients with lipodystrophy, speculate on the etiology of the disorders, and discuss how the use of murine models of lipodystrophy could be beneficial to address the question of the contribution of leptin to lipodystrophy-associated cardiovascular disease."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-1756",
            "name": "Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=22135 data-id=20150 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20150.1" data-recommended="" data-doi="10.12688/f1000research.20150.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-1756/v1/pdf?article_uuid=fcda0961-7e39-40e3-80ca-6ac8c2c2e96f" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-20150-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-20150-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-20150-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Bruder-Nascimento T, Kress TC and Belin de Chantemele EJ. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1756 (<a class=new-orange href="https://doi.org/10.12688/f1000research.20150.1" target=_blank>https://doi.org/10.12688/f1000research.20150.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-20150-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=20150 id=track-article-signin-20150 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20150?target=/articles/8-1756">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22135 /> <input name=articleId type=hidden value=20150 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Thiago Bruder-Nascimento<sup>1,2</sup>,&nbsp;</span><span class="">Taylor C. Kress<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:ebelindechanteme@augusta.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Eric J. Belin de Chantemele</span></a><a href="https://orcid.org/0000-0002-0184-3830" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0184-3830</div><sup>1,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Thiago Bruder-Nascimento<sup>1,2</sup>,&nbsp;</span><span class="">Taylor C. Kress<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:ebelindechanteme@augusta.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Eric J. Belin de Chantemele</span></a><a href="http://orcid.org/0000-0002-0184-3830" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0184-3830</div><sup>1,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 16 Oct 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.20150.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USA<br/> <sup>2</sup> Department of Pediatrics, Division of Endocrinology, University of Pittsburgh, Pittsburgh, PA, USA<br/> <sup>3</sup> Department of Medicine, Section of Cardiology, Medical College of Georgia at Augusta University, Augusta, GA, USA<br/> <p> <div class=margin-bottom> Thiago Bruder-Nascimento <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Taylor C. Kress <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Eric J. Belin de Chantemele <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=58206-54856></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=58205-54858></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=58204-54857></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Lipodystrophy is a disease characterized by a partial or total absence of adipose tissue leading to severe metabolic derangements including marked insulin resistance, type 2 diabetes, hypertriglyceridemia, and steatohepatitis. Lipodystrophy is also a source of major cardiovascular disorders which, in addition to hepatic failure and infection, contribute to a significant reduction in life expectancy. Metreleptin, the synthetic analog of the adipocyte-derived hormone leptin and current therapy of choice for patients with lipodystrophy, successfully improves metabolic function. However, while leptin has been associated with hypertension, vascular diseases, and inflammation in the context of obesity, it remains unknown whether its daily administration could further impair cardiovascular function in patients with lipodystrophy. The goal of this short review is to describe the cardiovascular phenotype of patients with lipodystrophy, speculate on the etiology of the disorders, and discuss how the use of murine models of lipodystrophy could be beneficial to address the question of the contribution of leptin to lipodystrophy-associated cardiovascular disease. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> lipodystrophy, cardiovascular disease, metreleptin, cardiomyopathy, hypertension </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Eric J. Belin de Chantemele (<a href="mailto:ebelindechanteme@augusta.edu">ebelindechanteme@augusta.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Eric J. Belin de Chantemele </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by an Established Investigator Award from the American Heart Association (19EIA34760167, to EB), a K99/R00 (1K99HL140139-01A1 and 4R00HL140139-03 to TBN) and R01s (1R01HL130301-01; 1R01HL147639-01A1 to EB) from the National Heart, Lung, and Blood Institute (NHLBI). <br> <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Bruder-Nascimento T <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Bruder-Nascimento T, Kress TC and Belin de Chantemele EJ. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1756 (<a href="https://doi.org/10.12688/f1000research.20150.1" target=_blank>https://doi.org/10.12688/f1000research.20150.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 16 Oct 2019, <b>8</b>(F1000 Faculty Rev):1756 (<a href="https://doi.org/10.12688/f1000research.20150.1" target=_blank>https://doi.org/10.12688/f1000research.20150.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 16 Oct 2019, <b>8</b>(F1000 Faculty Rev):1756 (<a href="https://doi.org/10.12688/f1000research.20150.1" target=_blank>https://doi.org/10.12688/f1000research.20150.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d18048e176>Introduction</h2><p class="" id=d18048e179>Lipodystrophy is a group of clinically heterogeneous diseases characterized by either complete or partial absence of adipose tissue which may occur in conjunction with adipose mass redistribution and can be of either congenital or acquired origin<sup><a href="#ref-1">1</a></sup>. While inherited forms of generalized or partial lipodystrophies are exceedingly rare (1 in 10 million and 1 in 1 million, respectively)<sup><a href="#ref-2">2</a></sup> and mainly caused by autosomal recessive mutations of the <i>AGPAT2</i>, Berardinelli-Seip congenital lipodystrophy 2 (<i>BSCL2</i>), caveolin 1 (<i>CAV1</i>), <i>PTRF</i> genes<sup><a href="#ref-2">2</a>–<a href="#ref-12">12</a></sup> or lamin A/C gene<sup><a href="#ref-13">13</a></sup>, acquired forms of lipodystrophy, on the other hand, have a relatively higher prevalence with an estimated number of 100,000 patients in the United States. Autoimmune disorders and medications including highly active antiretroviral therapy in HIV-infected patients are the leading causes of acquired generalized and partial lipodystrophy<sup><a href="#ref-5">5</a>,<a href="#ref-14">14</a>–<a href="#ref-16">16</a></sup>.</p><p class="" id=d18048e224>Regardless of the origin of the disease, patients with lipodystrophy share common metabolic abnormalities, which include marked insulin resistance, diabetes mellitus, and hypertriglyceridemia, the severity of which is typically related to the degree of fat loss<sup><a href="#ref-1">1</a></sup>. Metabolic derangements associated with lipodystrophy develop early in life and predispose patients to pancreatitis, non-alcoholic steatohepatitis (NASH), and hepatic failure<sup><a href="#ref-2">2</a>,<a href="#ref-5">5</a>,<a href="#ref-6">6</a>,<a href="#ref-17">17</a>–<a href="#ref-20">20</a></sup>, the latter being the first cause of morbidity and mortality and of substantial reduction in lifespan (of approximately 30 years) in patients with lipodystrophy<sup><a href="#ref-21">21</a></sup>. Although less studied and described, cardiovascular disorders including hypertrophic cardiomyopathy, hypertension, and atherosclerosis are also highly prevalent in lipodystrophic patients and additional major contributors to their shortened lifespan<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d18048e255>A key feature of lipodystrophy is a drastic reduction in the levels of adipocyte-derived hormones including leptin, which is a major regulator of appetite, insulin sensitivity, and liver function<sup><a href="#ref-22">22</a>–<a href="#ref-26">26</a></sup>. Strong basic science and clinical evidence have demonstrated that daily supplementation with leptin in rodent models of lipodystrophy and patients with lipodystrophy restores appetite, glycemia, and hepatic and renal function<sup><a href="#ref-7">7</a>,<a href="#ref-16">16</a>,<a href="#ref-18">18</a>,<a href="#ref-19">19</a>,<a href="#ref-27">27</a>–<a href="#ref-33">33</a></sup>. Based on these key findings, metreleptin, the recombinant human leptin analog, has been adopted as the therapeutic of choice for the treatment of lipodystrophy and approved by the US Food and Drug Administration (FDA) in February 2014 for the treatment of metabolic abnormalities in patients with congenital generalized and acquired lipodystrophy<sup><a href="#ref-34">34</a></sup>. However, leptin does more than targeting the metabolic system. Leptin is a pleiotropic hormone which controls numerous organ systems and has been positively associated with hypertrophic cardiomyopathy, hypertension, and vascular inflammation in the context of obesity<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. Whether restoring leptin levels in lipodystrophic patients with metreleptin represents a cardiovascular risk remains unclear. The goal of the present manuscript is to review the clinical and basic science literature to provide a current description of the cardiovascular diseases developed by lipodystrophy patients and rodent models of lipodystrophy and discuss the potential cardiovascular consequences of supplementing lipodystrophy patients chronically with leptin.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d18048e298>Cardiovascular diseases associated with lipodystrophy</h2><p class="" id=d18048e301>Cardiomyopathy, demonstrated by echocardiography and ECG, is a frequent finding in patients with both congenital and acquired forms of lipodystrophy, who develop similar cardiac abnormalities. A majority of patients with lipodystrophy presents hypertrophic cardiomyopathy as early as 6 months of age, as reported in a young girl with congenital generalized lipodystrophy due to seipin (<i>BSCL2</i>) mutation<sup><a href="#ref-37">37</a></sup>. Minimal numbers of patients with lipodystrophy have features of dilated cardiomyopathy. Classically, it is believed that congenital lipodystrophy patients with underlying <i>BSCL2</i> mutation have the highest prevalence of cardiomyopathy. Up to 80% of those affected have been reported to develop left ventricular hypertrophy with frequent abnormalities on ECGs resulting from long QT syndrome and a predisposition to tachyarrhythmias, including catecholaminergic polymorphic ventricular tachycardia and sudden cardiac death. Patients with underlying <i>AGPAT</i> mutation present a lower, but still high, prevalence (53%) of left ventricular hypertrophy. Lastly, patients with acquired generalized lipodystrophy have been reported to develop cardiac hypertrophy but of a significantly milder nature<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>.</p><p class="" id=d18048e324>Cardiomyopathies and sudden cardiac arrest contribute to the high prevalence of death from cardiovascular causes and to the very early mortality of patients with lipodystrophy. Owing to the rarity of the disease and the paucity of patients, actual data on the cause of death in lipodystrophy patients remain scarce. Nevertheless, a recent study in 20 congenital lipodystrophy patients with <i>BSCL2</i> mutation reported a mean age of death of 27 years old, with death from cardiovascular causes representing the third cause of death after hepatic failure and respiratory infection<sup><a href="#ref-16">16</a>,<a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>.</p><p class="" id=d18048e340>The underlying etiology of the cardiac abnormalities in lipodystrophy remain unclear. Severe insulin resistance and hyperlipidemia, which are characteristic of lipodystrophy patients, may provide the context for the development of hypertrophic cardiomyopathy. However, hypertrophic cardiomyopathy is more frequently seen in patients with <i>BSCL2</i> mutation, who have overall milder metabolic abnormalities (including lower triglyceride levels and glycated hemoglobin) than in the AGPAT or acquired lipodystrophy groups<sup><a href="#ref-38">38</a></sup>. Hypertension, another major contributor to cardiomyopathy, affects between 30 and 50% of patients with lipodystrophy<sup><a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup>. However, whether patients with <i>BSCL2</i> mutation who have the highest prevalence of cardiomyopathy are also more prone to hypertension remains unknown. One can hope that future clinical studies investigating the effects of metreleptin on cardiomyopathy will help address the question of the respective contribution of insulin resistance and hyperlipidemia, as well as hypertension, to lipodystrophy-associated cardiomyopathy. Indeed, metreleptin, the human recombinant leptin analog recently approved for the treatment of metabolic disorders associated with lipodystrophy, has proven to be efficacious at restoring insulin sensitivity and lipids levels<sup><a href="#ref-7">7</a></sup> but failed to restore blood pressure in patients with lipodystrophy<sup><a href="#ref-42">42</a></sup>. An improved cardiac function with metreleptin would support a role for metabolic disorders in lipodystrophy-associated cardiomyopathy. Experimental studies in animal models of lipodystrophy represent an additional avenue for investigation of the underlying mechanisms.</p><p class="" id=d18048e369>Dyslipidemia and diabetes are leading causes of vascular disease and atherosclerosis. However, despite high prevalence of marked lipidemia and diabetes, only a few cases of atherosclerosis have been reported in lipodystrophy patients with either <i>BSCL2</i> or <i>AGAPT</i> mutations<sup><a href="#ref-40">40</a></sup>. The relatively young age of the patients at the time of the study or death may explain the low prevalence for an age-related disease. In opposition to patients with other forms of lipodystrophy, patients with familial partial lipodystrophy (FPLD) and notably females suffering from the Dunnigan-type exhibit a high prevalence of coronary artery disease most likely caused by a very severe hypertriglyceridemia<sup><a href="#ref-40">40</a></sup>. Although metreleptin treatment has proven to markedly reduce triglyceride levels in FPLD, it remains unknown whether it could reduce the incidence of atherosclerosis in these patients<sup><a href="#ref-44">44</a></sup>.</p><p class="" id=d18048e391>Together, these reports highlight the severity of the cardiovascular disorders developed by lipodystrophy patients and our lack of knowledge of their pathogenesis as well as stress our need for additional studies investigating their underlying mechanisms.</p><p class="" id=d18048e394><a href="#T1">Table 1</a> summarizes the metabolic and cardiovascular alterations reported in patients with different forms of lipodystrophy.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Human lipodystrophy and their characteristics.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d18048e410 class=n-a></a><thead><a name=d18048e412 class=n-a></a><tr><a name=d18048e414 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d18048e415 class=n-a></a>Human disease</th><th align=left colspan=1 rowspan=1 valign=top><a name=d18048e418 class=n-a></a>Genetic changes</th><th align=left colspan=1 rowspan=1 valign=top><a name=d18048e421 class=n-a></a>Function of gene</th><th align=left colspan=1 rowspan=1 valign=top><a name=d18048e424 class=n-a></a>Metabolic Phenotype</th><th align=left colspan=1 rowspan=1 valign=top><a name=d18048e427 class=n-a></a>CV phenotype</th><th align=left colspan=1 rowspan=1 valign=top><a name=d18048e430 class=n-a></a>Ref</th></tr></thead><tbody><a name=d18048e434 class=n-a></a><tr><a name=d18048e436 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e437 class=n-a></a>Berardinelli-<br class=br>Seip congenital<br class=br>lipodystrophy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e444 class=n-a></a>Mutation in<br class=br><i>AGPAT2</i> and<br class=br><i>BSCL2</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e454 class=n-a></a>Important for lipid<br class=br>droplet formation<br class=br>and adipocyte<br class=br>maturation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e463 class=n-a></a>Enlarged and fatty liver,<br class=br>drastic reduction in fat<br class=br>mass, hyperinsulinemia,<br class=br>hyperglycemia, and<br class=br>hypertriglyceridemia</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e474 class=n-a></a>Cardiac hypertrophy,<br class=br>LV dysfunction,<br class=br>calcific aortic valve,<br class=br>and hypertension </td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e483 class=n-a></a><a href="#ref-37">37</a>,<a href="#ref-38">38</a>,<a href="#ref-43">43</a></td></tr><tr><a name=d18048e493 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e494 class=n-a></a>Mutant PPARγ</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e497 class=n-a></a>Heterozygous<br class=br>mutations in the<br class=br>ligand-binding<br class=br>domain of PPARγ</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e506 class=n-a></a>Adipogenesis<br class=br>and adipocyte<br class=br>differentiation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e513 class=n-a></a>Elevated glucose and<br class=br>insulin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e518 class=n-a></a>Hypertension</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e521 class=n-a></a><a href="#ref-57">57</a>,<a href="#ref-58">58</a></td></tr><tr><a name=d18048e528 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e529 class=n-a></a>Dunnigan type<br class=br>(FPLD2) </td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e534 class=n-a></a>Mutations in <i>LMNA</i><br class=br>encoding nuclear<br class=br>lamin A/C</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e543 class=n-a></a>Inhibits adipocyte<br class=br>differentiation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e548 class=n-a></a>Insulin resistance</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e551 class=n-a></a>Hypertension<br class=br>and moderate LV<br class=br>dysfunction and<br class=br>dilation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e560 class=n-a></a><a href="#ref-38">38</a>,<a href="#ref-59">59</a>,<a href="#ref-60">60</a></td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d18048e574 class=n-a></a><p id=d18048e576> AGPAT2, 1-acyl-sn-glycerol 3-phosphate O-acyltransferase 2; Bscl2, Berardinelli-Seipin congenital lipodystrophy 2; C/EBP, CCAAT-enhancer-binding proteins; CV, cardiovascular; FPLD2, familial partial lipodystrophy type 2; LV, left ventricle; PPARγ, peroxisome proliferator-activated receptor gamma; SREBP-1c, sterol regulatory element-binding protein 1.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d18048e585>Cardiovascular disease in mouse models of lipodystrophy</h2><p class="" id=d18048e588>The rare aspect of the disease, its difficult diagnosis, and its consequent paucity in patients represent major limiting factors to the study of the etiology and pathological manifestations of lipodystrophy. Fortunately, several mouse models, which reproduce the metabolic and cardiovascular abnormalities observed in humans with lipodystrophy, have been developed and employed to better analyze the origins and consequences of this rare syndrome<sup><a href="#ref-45">45</a>–<a href="#ref-47">47</a></sup>. The following section and <a href="#T2">Table 2</a> describe and discuss the phenotype of several of these models.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Mouse models of lipodystrophy and their characteristics.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d18048e612 class=n-a></a><thead><a name=d18048e614 class=n-a></a><tr><a name=d18048e616 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d18048e617 class=n-a></a>Mouse model</th><th align=center colspan=1 rowspan=1 valign=top><a name=d18048e620 class=n-a></a>Genetic<br class=br>manipulation</th><th align=center colspan=1 rowspan=1 valign=top><a name=d18048e625 class=n-a></a>Function of gene</th><th align=center colspan=1 rowspan=1 valign=top><a name=d18048e628 class=n-a></a>Metabolic<br class=br>phenotype</th><th align=center colspan=1 rowspan=1 valign=top><a name=d18048e633 class=n-a></a>CV<br class=br>phenotype</th><th align=center colspan=1 rowspan=1 valign=top><a name=d18048e638 class=n-a></a>Ref</th></tr></thead><tbody><a name=d18048e642 class=n-a></a><tr><a name=d18048e644 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e645 class=n-a></a>Caveolin 1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e648 class=n-a></a>Global deficiency</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e651 class=n-a></a>Role in lipid droplet<br class=br>formation by<br class=br>regulating lipids<br class=br>and phospholipid<br class=br>translocation across<br class=br>the plasma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e664 class=n-a></a>Elevated TG and<br class=br>reduced leptin plasma<br class=br>levels</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e671 class=n-a></a>Vascular dysfunction,<br class=br>right ventricular<br class=br>hypertrophy,<br class=br>cardiomyopathy,<br class=br>and protected from<br class=br>atherosclerosis<sup><a href="#ref-61">61</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e688 class=n-a></a><a href="#ref-49">49</a>,<a href="#ref-62">62</a>–<a href="#ref-64">64</a></td></tr><tr><a name=d18048e698 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e699 class=n-a></a>AGPAT2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e702 class=n-a></a>Global deficiency</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e705 class=n-a></a>Catalyzes the<br class=br>acylation of<br class=br>lysophosphatidic acid<br class=br>to phosphatidic acid</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e714 class=n-a></a>Hyperglycemia,<br class=br>elevated HbA1c,<br class=br>hyperinsulinemia,<br class=br>enlarged livers, and<br class=br>very low adiponectin<br class=br>and leptin levels</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e727 class=n-a></a>Not described</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e730 class=n-a></a><a href="#ref-65">65</a>–<a href="#ref-67">67</a></td></tr><tr><a name=d18048e737 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e738 class=n-a></a>Bscl2/Seipin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e741 class=n-a></a>Global </td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e744 class=n-a></a>Important for lipid<br class=br>droplet formation and<br class=br>adipocyte maturation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e751 class=n-a></a>Enlarged and fatty liver,<br class=br>drastic reduction in fat<br class=br>mass, plasma leptin,<br class=br>and adiponectin levels,<br class=br>hyperinsulinemia, and<br class=br>hyperglycemia</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e764 class=n-a></a>Cardiac hypertrophy,<br class=br>cardiac dysfunction,<br class=br>and endothelial<br class=br>dysfunction </td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e773 class=n-a></a><a href="#ref-45">45</a>,<a href="#ref-48">48</a>,<a href="#ref-56">56</a>,<a href="#ref-68">68</a></td></tr><tr><a name=d18048e786 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e787 class=n-a></a>Bscl2/Seipin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e790 class=n-a></a>Adipocyte-specific<br class=br>deficiency </td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e795 class=n-a></a>Important for lipid<br class=br>droplet formation and<br class=br>adipocyte maturation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e802 class=n-a></a>Enlarged and fatty liver,<br class=br>drastic reduction in fat<br class=br>mass, plasma leptin,<br class=br>and adiponectin levels,<br class=br>hyperinsulinemia, and<br class=br>hyperglycemia </td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e815 class=n-a></a>Not described</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e818 class=n-a></a><a href="#ref-48">48</a></td></tr><tr><a name=d18048e822 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e823 class=n-a></a>PPARγ</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e826 class=n-a></a>Adipocyte-specific<br class=br>deficiency</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e831 class=n-a></a>Adipogenesis<br class=br>and adipocyte<br class=br>differentiation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e838 class=n-a></a>Enlarged and fatty<br class=br>liver, reduced leptin,<br class=br>diabetes, and elevated<br class=br>TG</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e847 class=n-a></a>Not described</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e850 class=n-a></a><a href="#ref-50">50</a>,<a href="#ref-51">51</a></td></tr><tr><a name=d18048e858 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e859 class=n-a></a>Pro-renin<br class=br>receptor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e864 class=n-a></a>Adipocyte-specific<br class=br>deficiency</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e869 class=n-a></a>Receptor for pro-renin<br class=br>or renin </td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e874 class=n-a></a>Hyperinsulinemia,<br class=br>enlarged liver and<br class=br>pancreas, and reduced<br class=br>leptin plasma levels</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e883 class=n-a></a>Hypertension</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e886 class=n-a></a><a href="#ref-52">52</a>,<a href="#ref-69">69</a></td></tr><tr><a name=d18048e893 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e894 class=n-a></a>SREBP-1c</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e897 class=n-a></a>Adipocyte-specific<br class=br>overexpression</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e902 class=n-a></a>Lipid biosynthesis in<br class=br>animal cells</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e907 class=n-a></a>Hyperinsulinemia,<br class=br>hyperglycemia, insulin<br class=br>resistance, fatty liver,<br class=br>and reduced leptin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e916 class=n-a></a>Not described</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e919 class=n-a></a><a href="#ref-47">47</a>,<a href="#ref-53">53</a></td></tr><tr><a name=d18048e926 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e927 class=n-a></a>A-ZIP/F-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e930 class=n-a></a>Adipocyte-specific<br class=br>deficiency</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e935 class=n-a></a>ZIP/F prevents the<br class=br>DNA binding of B-ZIP<br class=br>transcription factors<br class=br>of both the C/EBP<br class=br>and Jun families</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e946 class=n-a></a>Hyperinsulinemia,<br class=br>hyperglycemia,<br class=br>elevated TG, and<br class=br>reduced leptin plasma<br class=br>levels</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e957 class=n-a></a>Vascular dysfunction<br class=br>and remodeling and<br class=br>hypertension</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18048e964 class=n-a></a><a href="#ref-54">54</a>,<a href="#ref-70">70</a>,<a href="#ref-71">71</a></td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d18048e978 class=n-a></a><p id=d18048e980> AGPAT2, 1-acyl-sn-glycerol 3-phosphate O-acyltransferase 2; Bscl2, Berardinelli-Seipin congenital lipodystrophy 2; C/EBP, CCAAT-enhancer-binding proteins; CV, cardiovascular; PPARγ, peroxisome proliferator-activated receptor gamma; SREBP-1c, Sterol regulatory element-binding protein 1; TG, triglycerides.</p></div></div></div><p class="" id=d18048e986>Constitutive deletion of <i>BSCL2</i><sup><a href="#ref-48">48</a></sup> and <i>Cav1<sup>–/–</sup></i><sup><a href="#ref-49">49</a></sup> or selective deletion of peroxisome proliferator activated receptor γ (PPARγ)<sup><a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup> and pro-renin receptor<sup><a href="#ref-52">52</a></sup> in adipocytes has been shown to reproduce the human congenital generalized lipodystrophy syndrome in mice. Each of these mouse models exhibit a near-complete absence of adipose tissue associated with impaired glucose tolerance and hyperlipidemia. Similarly, overexpression of the sterol regulatory element-binding protein-1c (SREBP-1c)<sup><a href="#ref-47">47</a>,<a href="#ref-53">53</a></sup> and expression of the dominant negative A-ZIP/F-1 protein<sup><a href="#ref-54">54</a></sup> in adipose tissue reproduce well the human lipodystrophy phenotype in terms of fat mass and distribution as well as metabolic alterations. This close proximity between the metabolic phenotype of these mouse models and of human patients makes these murine models the ideal tool to investigate the etiology of cardiovascular disease in lipodystrophy.</p><p class="" id=d18048e1026>The seipin-deficient (<i>BSCL2<sup>–/–</sup></i>) mouse is the model that has been the most extensively studied for its cardiovascular phenotype. Several groups have observed that <i>BSCL2<sup>–/–</sup></i> mice, just like lipodystrophy patients<sup><a href="#ref-37">37</a></sup>, exhibit cardiac hypertrophy very early in life, as early as postnatal day 10<sup><a href="#ref-55">55</a></sup>. Cardiac hypertrophy persists throughout adulthood and progresses to cardiomyopathy with aging<sup><a href="#ref-55">55</a></sup>. Results gathered with independent lines of <i>BSCL2</i> knockout mice concur on the structural and hemodynamic alterations induced by lipodystrophy but diverge on the pathogenesis of the cardiac phenotype. Joubert <i>et al</i>.<sup><a href="#ref-56">56</a></sup> reported no intramyocardial lipid accumulation or lipotoxic hallmarks but detected increased myocardial glucose uptake and O-GlycNAcylated protein in <i>BSCL2<sup>–/–</sup></i> hearts, in support of a cardiac glucose overload. Additional arguments in furtherance of an impaired cardiac glucose metabolism were provided by demonstrating that treatment with the hypoglycemic sodium glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin prevented the development of hypertrophic cardiomyopathy in <i>BSCL2<sup>–/–</sup></i> mice. Zhou <i>et al</i>.<sup><a href="#ref-55">55</a></sup>, on the other hand, identified an important link between hyperinsulinemia and organomegaly in lipodystrophic mice. They showed that activation of prohypertrophic insulin-like growth factor 1 receptor (IGF1R)-mediated PI3K/AKT signaling contributes to cardiac hypertrophy in <i>BSCL2<sup>–/–</sup></i> mice. They also identified a unique pattern of cardiac lipid remodeling with reduced cardiac steatosis associated with adipose triglyceride lipase (ATGL) overexpression in hearts of <i>BSCL2<sup>–/–</sup></i> mice and showed that ATGL haploinsufficiency could reverse lipodystrophy, insulin resistance, and cardiac derangements. While these two studies depart on the underlying pathological mechanisms of hypertrophic cardiomyopathy in <i>BSCL2<sup>–/–</sup></i> mice, they strongly support a role for metabolic alterations. Interestingly, using the exact same mouse as the mouse employed by Chen <i>et al</i>.<sup><a href="#ref-45">45</a></sup> and Zhou <i>et al</i>.<sup><a href="#ref-55">55</a></sup>, our group recently reported that lipodystrophy impairs aortic endothelium-dependent relaxation by mechanisms independent of metabolic function. Indeed, we showed that restoration of glycemia via SGLT2 inhibition failed to restore endothelial function. However, we demonstrated that the absence of adipose tissue characteristic of lipodystrophy induced a reduction in systemic leptin levels which diminished endothelial leptin signaling and caused endothelial dysfunction via an overproduction of reactive oxygen species by endothelial NADPH oxidase 1 (Nox1)<sup><a href="#ref-68">68</a></sup>. Together, these observations further highlight the complexity of the disease and suggest that metabolic alterations are not the only cause of cardiovascular disease in lipodystrophy.</p><p class="" id=d18048e1115>The <i>Cav1<sup>–/–</sup></i> mouse is another model that has been used to study lipodystrophy and also present cardiomyopathy<sup><a href="#ref-49">49</a>,<a href="#ref-62">62</a>–<a href="#ref-64">64</a>,<a href="#ref-72">72</a></sup>. Differently from <i>BSCL2<sup>–/–</sup></i> mice, <i>Cav1<sup>–/–</sup></i> mice exhibit concentric left ventricular hypertrophy and dilated right ventricular hypertrophy. The discrepancy in the cardiac phenotype between <i>BSCL2<sup>–/–</sup></i> and <i>Cav1<sup>–/–</sup></i> might find its origin in the etiology of the cardiomyopathy. Indeed, as described above, metabolic disorders, notably insulin resistance and hyperglycemia, appear as the primary causes of cardiomyopathy in <i>BSCL2<sup>–/–</sup></i> mice. In opposition, in <i>Cav1<sup>–/–</sup></i> mice, cardiomyopathy was shown to be secondary to Cav1 deletion and pulmonary hypertension. Indeed, selective restoration of Cav1 expression in endothelial cells completely rescued pulmonary hypertension and cardiac hypertrophy in <i>Cav1<sup>–/–</sup></i> mice<sup><a href="#ref-73">73</a></sup>. Remarkably, <i>Cav1<sup>–/–</sup></i> mice are protected from atherosclerosis, again through mechanisms independent of lipodystrophy likely involving reduction in LDL infiltration into the artery wall, increased nitric oxide production, and reduction in the expression of leukocyte adhesion molecules<sup><a href="#ref-61">61</a></sup>. Therefore, the <i>Cav1<sup>–/–</sup></i> mouse may be less relevant to the study of lipodystrophy and its cardiovascular consequences.</p><p class="" id=d18048e1191>A key feature of lipodystrophy is dyslipidemia, notably hyperlipidemia which, added to insulin resistance and diabetes, places patients with lipodystrophy at a high risk for atherosclerotic cardiovascular disease<sup><a href="#ref-74">74</a>–<a href="#ref-79">79</a></sup>. To investigate whether lipodystrophy predisposes to atherosclerosis, Wang <i>et al</i>.<sup><a href="#ref-74">74</a></sup> crossed <i>BSCL2<sup>–/–</sup></i> with low-density lipoprotein receptor (<i>LDLr<sup>–/–</sup></i>) knockout mice, a mouse model of atherosclerosis. As observed in lipodystrophic patients<sup><a href="#ref-40">40</a></sup>, <i>LDLr<sup>–/–</sup> BSCL2<sup>–/–</sup></i> mice present with accelerated atherosclerosis, as reflected by spontaneous plaque formation on chow diet and exacerbation of atherosclerotic lesions on atherogenic diet<sup><a href="#ref-74">74</a></sup>. The absence of adipocytes, which decreases the potential for adipose cholesterol clearance, most likely explains the extremely high rise in plasma cholesterol levels in <i>LDLr<sup>–/–</sup> BSCL2<sup>–/–</sup></i> mice which itself predisposed lipodystrophic mice to atherosclerosis<sup><a href="#ref-74">74</a></sup>.</p><p class="" id=d18048e1247>Lastly, mouse models of lipodystrophy, as do patients, present with hypertension<sup><a href="#ref-27">27</a>,<a href="#ref-43">43</a></sup>. Experiments conducted in transgenic A-ZIP/F-1 mice<sup><a href="#ref-70">70</a>,<a href="#ref-80">80</a></sup> and adipose tissue pro-renin receptor-deficient mice<sup><a href="#ref-52">52</a></sup> revealed elevated systolic blood pressure associated with hyperactivation of the renin angiotensin system (RAS). Angiotensin-converting enzyme inhibition<sup><a href="#ref-81">81</a></sup> and angiotensin type 1 receptor blockade<sup><a href="#ref-80">80</a></sup> restored blood pressure in these two mouse models of lipodystrophy, which further supports the contribution of RAS to the development of hypertension in mouse models of lipodystrophy and presents RAS blockade as a potential avenue for the treatment of cardiovascular disease associated with lipodystrophy. However, whether RAS overactivation is consecutive to metabolic alterations remains to be determined.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d18048e1279>Metreleptin and lipodystrophy-associated cardiovascular disease</h2><p class="" id=d18048e1282>Following many successful trials, the FDA has approved leptin (metreleptin) for the treatment of non-HIV-related forms of generalized lipodystrophy. Leptin replacement therapy with metreleptin has, in many cases, reversed the metabolic complications, with improvements in glucose-insulin-lipid homeostasis and regression of fatty liver disease<sup><a href="#ref-7">7</a>,<a href="#ref-16">16</a>,<a href="#ref-18">18</a>,<a href="#ref-19">19</a>,<a href="#ref-27">27</a>–<a href="#ref-33">33</a></sup>. An aspect of the treatment that remains ill-defined is whether metreleptin improves or alters cardiovascular function in lipodystrophic patients. Compelling basic science and clinical evidence indicate that excess leptin elevates blood pressure and impairs vascular function via sympatho-activation in males<sup><a href="#ref-82">82</a>–<a href="#ref-86">86</a></sup> and aldosterone production in females<sup><a href="#ref-82">82</a>,<a href="#ref-87">87</a>,<a href="#ref-88">88</a></sup>. Therefore, concerns have been raised regarding the potential deleterious cardiovascular consequences of daily leptin injections. Recent results by Brown <i>et al</i>. partially dissipated these concerns by reporting that metreleptin did not elevate blood pressure in a relatively large population of lipodystrophic patients (107 patients)<sup><a href="#ref-42">42</a></sup>. Based on their results, the authors concluded that there was a lack of contribution of leptin to the development of hypertension and a lack of translatability of the results obtained in murine models. However, the significant improvements in glycemia, insulin resistance, and liver and renal function associated with metreleptin treatment<sup><a href="#ref-18">18</a></sup> were not considered by the authors to reach their conclusions. Indeed, insulin resistance has been presented as a major risk factor for hypertension<sup><a href="#ref-89">89</a>,<a href="#ref-90">90</a></sup>. Therefore, the significant improvement in the metabolic profile of the lipodystrophy patients on metreleptin most certainly compensated for the indisputable effects of leptin on sympathetic tone<sup><a href="#ref-91">91</a></sup>. This may explain the lack of significant decreases in pressure in lipodystrophy patients on metreleptin. In addition, besides increasing sympathetic activity, leptin exerts vascular actions which could provide additional explanations for the lack of increase in blood pressure. Early work by the group of Lembo <i>et al</i>., and supported by others, demonstrated that leptin not only relaxes blood vessels via NO-dependent mechanisms<sup><a href="#ref-92">92</a>,<a href="#ref-93">93</a></sup> but also controls vascular integrity by protecting vessels from neointima formation, excess endothelin 1 production, and increasing PPARγ activity<sup><a href="#ref-94">94</a></sup>. Furthermore, recent results by our group show that leptin replacement therapy restores endothelium-dependent relaxation via direct activation of endothelial leptin receptor and reduction in Nox1-derived ROS production, likely via PPARγ-dependent mechanisms, in <i>BSCL2<sup>–/–</sup></i> mice<sup><a href="#ref-57">57</a></sup>. Taken together, these results further support the direct vascular effects of leptin and indicate that metreleptin treatment should improve vascular function in lipodystrophy patients.</p><p class="" id=d18048e1368>Other potential concerns are the chronic effects of metreleptin on cardiac function and remodeling. Indeed, while compelling <i>in vitro</i> studies have shown that leptin promotes human and rodent cardiomyocyte hyperplasia<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>, several clinical studies have established a positive correlation between leptin and left ventricular hypertrophy after adjustment for body mass index and present leptin as an independent predictor of incident heart failure<sup><a href="#ref-97">97</a></sup>. Conversely, elegant rescue experiments involving either selective restoration of leptin receptor expression in cardiomyocytes of leptin receptor-deficient mice (<i>db/db</i>) or restoration of leptin levels in leptin-deficient (<i>ob/ob</i>) mice report a decreased heart mass and reduction in left ventricular wall thickness in response to leptin, supportive of the cardiac protective effects of leptin. In addition, selective cardiac leptin receptor deficiency resulted in transient left ventricular dysfunction and dramatic reduction in ejection fraction, while cardiac-specific overexpression of leptin receptors normalized cardiac triglyceride levels and diastolic function in <i>db/db</i><sup><a href="#ref-97">97</a></sup>. All together, these data derived from murine models support a beneficial role for leptin in cardiac function and metabolism (protection from lipotoxicity) but drastically contrast with the clinical studies. This further raises the question of the potential contribution of leptin deficiency to the cardiac disorders associated with lipodystrophy and of the effects of daily metreleptin injections on the severely impaired heart function of lipodystrophic patients. Additional studies are warranted to address these concerns.</p><p class="" id=d18048e1398>Lastly, although not tested yet, one can reasonably speculate that metreleptin exerts protective effects against atherosclerosis. While insulin resistance, diabetes, and, more specifically, hyperlipidemia are leading risk factors for atherosclerosis, compelling evidence from relatively large (66 patients) studies have demonstrated that long-term treatment with metreleptin resulted in sustained improvements in hypertriglyceridemia, glycemic control, and liver volume which led to discontinuation of insulin, oral anti-diabetics, and lipid-lowering medications in more than 25% of patients on metreleptin<sup><a href="#ref-18">18</a></sup>. Therefore, one can soundly anticipate that metreleptin will significantly reduce the risk for atherosclerosis in lipodystrophy patients through centrally orchestrated mechanisms reducing food intake but also through direct and local effects of leptin activating β-oxidation of fatty acids and preventing lipogenesis in the liver and skeletal muscles<sup><a href="#ref-98">98</a></sup>. Remarkably, another recent study reported that metreleptin treatment for 1 year reduced plasma levels of the proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regulator of cholesterol metabolism, in humans with congenital lipodystrophy<sup><a href="#ref-99">99</a></sup>. This provides an additional potential mechanism whereby metreleptin might prevent atherogenesis in lipodystrophy patients. However, the hypothesis that metreleptin protects from atherosclerosis remains to be tested. Less promising and beneficial evidence from animal studies further support this need for additional studies. Indeed, while leptin deficiency has been shown to protect apolipoprotein-E-deficient mice fed an atherogenic diet from the development of atherosclerosis lesions, exogenous leptin significantly increases atherosclerotic areas in apoE-deficient mice. In addition, leptin has been shown to promote the differentiation of macrophages towards a proinflammatory phenotype<sup><a href="#ref-100">100</a></sup>, which is another major contributor to atherosclerosis. It is therefore crucial to determine whether metreleptin prevents or exacerbates atherosclerogenesis in lipodystrophy patients.</p><p class="" id=d18048e1417>Recent studies following patients for up to 3 years have reported that metreleptin is well tolerated in patients with lipodystrophy<sup><a href="#ref-18">18</a></sup>. However, as with any other drug, metreleptin has been associated with a few side effects. Antimetreleptin antibodies with <i>in vitro</i> neutralizing activity, which could potentially reduce the drug’s efficacy or even inhibit endogenous leptin activity<sup><a href="#ref-101">101</a></sup>, have been shown to develop in most patients within 4–6 months but to decrease with continuous therapy. In addition, few patients under metreleptin treatment have been shown to develop T-cell lymphoma. However, whether metreleptin is truly a contributor requires further investigation, as patients with lipodystrophy appear to be at a higher risk for lymphoma than the general population, likely because of underlying autoimmunity<sup><a href="#ref-102">102</a></sup>. Therefore, metreleptin-associated side effects may still deserve some attention.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d18048e1438>Conclusion</h2><p class="" id=d18048e1441>In summary, while the current literature on lipodystrophy focuses mostly on the metabolic disorders associated with the syndrome, cardiovascular diseases, notably hypertension and cardiomyopathy (<a href="#f1">Figure 1</a>), also represent a major health concern in patients with lipodystrophy and contribute to their very early mortality. Here, we speculated that the metreleptin regimen provided to lipodystrophy patients may improve cardiovascular function through its beneficial effects on glycemia, lipidemia, and liver function. We also stressed that metreleptin may affect cardiac and vascular function through direct control of cardiomyocyte and endothelial cell function and highlighted the need for studies investigating whether metreleptin improves or impairs the function of these two types of cells. We presented several mouse models of lipodystrophy which reproduce well the metabolic and cardiovascular phenotype of patients with lipodystrophy and represent the perfect avenue to investigate the direct effects of leptin on the cardiovascular system and dissipate any potential harmful effect.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/22135/cfa009ab-416d-4bff-a836-8765a505c25c_figure1.gif"><img alt="cfa009ab-416d-4bff-a836-8765a505c25c_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/22135/cfa009ab-416d-4bff-a836-8765a505c25c_figure1.gif"></a><div class=caption><h3>Figure 1. Potential Mechanisms leading to cardiovascular disease in lipodystrophy.</h3><p id=d18048e1457>Lipodystrophy is associated with a drastic reduction in adiposity and leptin plasma levels, which lead to hyperglycemia, lipotoxicity, and decreased cellular leptin signaling. These changes have been associated with non-alcoholic fatty liver disease (NAFLD) endothelial dysfunction, hypertension, and cardiac diseases.</p></div></div></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d18048e1468 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d18681>References</h2><div class="section ref-list"><a name=d18048e1468 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d18048e1475 class=n-a></a>Fiorenza CG, Chou SH, Mantzoros CS: Lipodystrophy: pathophysiology and advances in treatment. <i>Nat Rev Endocrinol.</i> 2011; <b>7</b>(3): 137–50. <a target=xrefwindow id=d18048e1483 href="http://www.ncbi.nlm.nih.gov/pubmed/21079616">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1486 href="https://doi.org/10.1038/nrendo.2010.199">Publisher Full Text </a> | <a target=xrefwindow id=d18048e1489 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3150735">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d18048e1498 class=n-a></a>Yupanqui-Lozno H, Bastarrachea RA, Yupanqui-Velazco ME, <i> et al.</i>: Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters with Severe Obesity. <i>Genes (Basel).</i> 2019; <b>10</b>(5): 342. <a target=xrefwindow id=d18048e1509 href="http://www.ncbi.nlm.nih.gov/pubmed/31067764">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1512 href="https://doi.org/10.3390/genes10050342">Publisher Full Text </a> | <a target=xrefwindow id=d18048e1516 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6562380">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d18048e1525 class=n-a></a>Metreleptin (Myalept): a leptin analog for generalized lipodystrophy. <i>Med Lett Drugs Ther.</i> 2015; <b>57</b>(1460): 13–4. <a target=xrefwindow id=d18048e1533 href="http://www.ncbi.nlm.nih.gov/pubmed/25581107">PubMed Abstract </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d18048e1542 class=n-a></a>Diker-Cohen T, Cochran E, Gorden P, <i> et al.</i>: Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin. <i>J Clin Endocrinol Metab.</i> 2015; <b>100</b>(5): 1802–10. <a target=xrefwindow id=d18048e1553 href="http://www.ncbi.nlm.nih.gov/pubmed/25734254">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1556 href="https://doi.org/10.1210/jc.2014-4491">Publisher Full Text </a> | <a target=xrefwindow id=d18048e1560 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4422900">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d18048e1569 class=n-a></a>Garg A: Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. <i>J Clin Endocrinol Metab.</i> 2011; <b>96</b>(11): 3313–25. <a target=xrefwindow id=d18048e1577 href="http://www.ncbi.nlm.nih.gov/pubmed/21865368">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1580 href="https://doi.org/10.1210/jc.2011-1159">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d18048e1590 class=n-a></a>Hegele RA, Joy TR, Al-Attar SA, <i> et al.</i>: <i>Thematic review series: Adipocyte Biology</i>. Lipodystrophies: windows on adipose biology and metabolism. <i>J Lipid Res.</i> 2007; <b>48</b>(7): 1433–44. <a target=xrefwindow id=d18048e1604 href="http://www.ncbi.nlm.nih.gov/pubmed/17374881">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1608 href="https://doi.org/10.1194/jlr.R700004-JLR200">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d18048e1617 class=n-a></a>Oral EA, Simha V, Ruiz E, <i> et al.</i>: Leptin-replacement therapy for lipodystrophy. <i>N Engl J Med.</i> 2002; <b>346</b>(8): 570–8. <a target=xrefwindow id=d18048e1628 href="http://www.ncbi.nlm.nih.gov/pubmed/11856796">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1631 href="https://doi.org/10.1056/NEJMoa012437">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d18048e1640 class=n-a></a>Patni N, Garg A: Congenital generalized lipodystrophies--new insights into metabolic dysfunction. <i>Nat Rev Endocrinol.</i> 2015; <b>11</b>(9): 522–34. <a target=xrefwindow id=d18048e1648 href="http://www.ncbi.nlm.nih.gov/pubmed/26239609">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1651 href="https://doi.org/10.1038/nrendo.2015.123">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d18048e1660 class=n-a></a>Magré J, Delépine M, Khallouf E, <i> et al.</i>: Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. <i>Nat Genet.</i> 2001; <b>28</b>(4): 365–70. <a target=xrefwindow id=d18048e1671 href="http://www.ncbi.nlm.nih.gov/pubmed/11479539">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1674 href="https://doi.org/10.1038/ng585">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1099136"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e1683 class=n-a></a>Kim CA, Delépine M, Boutet E, <i> et al.</i>: Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. <i>J Clin Endocrinol Metab.</i> 2008; <b>93</b>(4): 1129–34. <a target=xrefwindow id=d18048e1694 href="http://www.ncbi.nlm.nih.gov/pubmed/18211975">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1697 href="https://doi.org/10.1210/jc.2007-1328">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1099136">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1163794"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e1710 class=n-a></a>Hayashi YK, Matsuda C, Ogawa M, <i> et al.</i>: Human <i>PTRF</i> mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. <i>J Clin Invest.</i> 2009; <b>119</b>(9): 2623–33. <a target=xrefwindow id=d18048e1724 href="http://www.ncbi.nlm.nih.gov/pubmed/19726876">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1728 href="https://doi.org/10.1172/JCI38660">Publisher Full Text </a> | <a target=xrefwindow id=d18048e1731 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2735915">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1163794">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d18048e1746 class=n-a></a>Agarwal AK, Arioglu E, De Almeida S, <i> et al.</i>: AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. <i>Nat Genet.</i> 2002; <b>31</b>(1): 21–3. <a target=xrefwindow id=d18048e1757 href="http://www.ncbi.nlm.nih.gov/pubmed/11967537">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1760 href="https://doi.org/10.1038/ng880">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d18048e1769 class=n-a></a>Genschel J, Schmidt HH: Mutations in the LMNA gene encoding lamin A/C. <i>Hum Mutat.</i> 2000; <b>16</b>(6): 451–9. <a target=xrefwindow id=d18048e1777 href="http://www.ncbi.nlm.nih.gov/pubmed/11102973">PubMed Abstract </a> | <a target="xrefwindow" id="d18048e1780" href="https://doi.org/10.1002/1098-1004(200012)16:6<451::AID-HUMU1&gt;3.0.CO;2-9">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d18048e1789 class=n-a></a>Chan JL, Lutz K, Cochran E, <i> et al.</i>: Clinical effects of long-term metreleptin treatment in patients with lipodystrophy. <i>Endocr Pract.</i> 2011; <b>17</b>(6): 922–32. <a target=xrefwindow id=d18048e1800 href="http://www.ncbi.nlm.nih.gov/pubmed/22068254">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1803 href="https://doi.org/10.4158/EP11229.OR">Publisher Full Text </a> | <a target=xrefwindow id=d18048e1807 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3498767">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d18048e1816 class=n-a></a>Goetzman ES, Tian L, Nagy TR, <i> et al.</i>: HIV protease inhibitor ritonavir induces lipoatrophy in male mice. <i>AIDS Res Hum Retroviruses.</i> 2003; <b>19</b>(12): 1141–50. <a target=xrefwindow id=d18048e1827 href="http://www.ncbi.nlm.nih.gov/pubmed/14709251">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1830 href="https://doi.org/10.1089/088922203771881248">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d18048e1839 class=n-a></a>Machado MV, Cortez-Pinto H: Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already? <i>Expert Rev Gastroenterol Hepatol.</i> 2013; <b>7</b>(6): 513–5. <a target=xrefwindow id=d18048e1847 href="http://www.ncbi.nlm.nih.gov/pubmed/23985000">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1850 href="https://doi.org/10.1586/17474124.2013.814903">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d18048e1859 class=n-a></a>Akinci G, Akinci B: Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy. <i>Recent Pat Endocr Metab Immune Drug Discov.</i> 2015; <b>9</b>(2): 74–8. <a target=xrefwindow id=d18048e1867 href="http://www.ncbi.nlm.nih.gov/pubmed/26556498">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1870 href="https://doi.org/10.2174/1574892811666151111142554">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733036725"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e1880 class=n-a></a>Brown RJ, Oral EA, Cochran E, <i> et al.</i>: Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. <i>Endocrine.</i> 2018; <b>60</b>(3): 479–489. <a target=xrefwindow id=d18048e1891 href="http://www.ncbi.nlm.nih.gov/pubmed/29644599">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1894 href="https://doi.org/10.1007/s12020-018-1589-1">Publisher Full Text </a> | <a target=xrefwindow id=d18048e1898 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5936645">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733036725">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d18048e1912 class=n-a></a>Ebihara K, Kusakabe T, Hirata M, <i> et al.</i>: Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. <i>J Clin Endocrinol Metab.</i> 2007; <b>92</b>(2): 532–41. <a target=xrefwindow id=d18048e1923 href="http://www.ncbi.nlm.nih.gov/pubmed/17118991">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1926 href="https://doi.org/10.1210/jc.2006-1546">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d18048e1935 class=n-a></a>Muniyappa R, Brown RJ, Mari A, <i> et al.</i>: Effects of leptin replacement therapy on pancreatic β-cell function in patients with lipodystrophy. <i>Diabetes Care.</i> 2014; <b>37</b>(4): 1101–7. <a target=xrefwindow id=d18048e1946 href="http://www.ncbi.nlm.nih.gov/pubmed/24496806">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1949 href="https://doi.org/10.2337/dc13-2040">Publisher Full Text </a> | <a target=xrefwindow id=d18048e1953 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3964492">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733419886"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e1962 class=n-a></a>Lima JG, Nobrega LHC, Lima NN, <i> et al.</i>: Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy. <i>PLoS One.</i> 2018; <b>13</b>(6): e0199052. <a target=xrefwindow id=d18048e1973 href="http://www.ncbi.nlm.nih.gov/pubmed/29883474">PubMed Abstract </a> | <a target=xrefwindow id=d18048e1976 href="https://doi.org/10.1371/journal.pone.0199052">Publisher Full Text </a> | <a target=xrefwindow id=d18048e1980 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5993255">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733419886">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d18048e1993 class=n-a></a>McGuire MJ, Ishii M: Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies. <i>Cell Mol Neurobiol.</i> 2016; <b>36</b>(2): 203–17. <a target=xrefwindow id=d18048e2001 href="http://www.ncbi.nlm.nih.gov/pubmed/26993509">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2004 href="https://doi.org/10.1007/s10571-015-0282-7">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2007 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4846558">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d18048e2016 class=n-a></a>Pocai A, Morgan K, Buettner C, <i> et al.</i>: Central leptin acutely reverses diet-induced hepatic insulin resistance. <i>Diabetes.</i> 2005; <b>54</b>(11): 3182–9. <a target=xrefwindow id=d18048e2027 href="http://www.ncbi.nlm.nih.gov/pubmed/16249443">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2030 href="https://doi.org/10.2337/diabetes.54.11.3182">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d18048e2040 class=n-a></a>Haque MS, Minokoshi Y, Hamai M, <i> et al.</i>: Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. <i>Diabetes.</i> 1999; <b>48</b>(9): 1706–12. <a target=xrefwindow id=d18048e2051 href="http://www.ncbi.nlm.nih.gov/pubmed/10480598">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2054 href="https://doi.org/10.2337/diabetes.48.9.1706">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d18048e2063 class=n-a></a>Minokoshi Y, Haque MS, Shimazu T: Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. <i>Diabetes.</i> 1999; <b>48</b>(2): 287–91. <a target=xrefwindow id=d18048e2071 href="http://www.ncbi.nlm.nih.gov/pubmed/10334303">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2074 href="https://doi.org/10.2337/diabetes.48.2.287">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d18048e2083 class=n-a></a>Toda C, Shiuchi T, Lee S, <i> et al.</i>: Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. <i>Diabetes.</i> 2009; <b>58</b>(12): 2757–65. <a target=xrefwindow id=d18048e2094 href="http://www.ncbi.nlm.nih.gov/pubmed/19752162">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2097 href="https://doi.org/10.2337/db09-0638">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2101 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2780865">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727460161"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e2110 class=n-a></a>Brown RJ, Meehan CA, Cochran E, <i> et al.</i>: Effects of Metreleptin in Pediatric Patients With Lipodystrophy. <i>J Clin Endocrinol Metab.</i> 2017; <b>102</b>(5): 1511–1519. <a target=xrefwindow id=d18048e2121 href="http://www.ncbi.nlm.nih.gov/pubmed/28324110">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2124 href="https://doi.org/10.1210/jc.2016-3628">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2128 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5443330">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727460161">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733164306"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e2141 class=n-a></a>Brown RJ, Valencia A, Startzell M, <i> et al.</i>: Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy. <i>J Clin Invest.</i> 2018; <b>128</b>(8): 3504–3516. <a target=xrefwindow id=d18048e2152 href="http://www.ncbi.nlm.nih.gov/pubmed/29723161">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2155 href="https://doi.org/10.1172/JCI95476">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2159 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6063484">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733164306">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d18048e2172 class=n-a></a>Inui A: Leptin-replacement therapy in lipodystrophy. <i>N Engl J Med.</i> 2002; <b>346</b>(25): 2009; author reply 2009–10. <a target=xrefwindow id=d18048e2180 href="http://www.ncbi.nlm.nih.gov/pubmed/12078706">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2183 href="https://doi.org/10.1056/NEJM200206203462515">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d18048e2193 class=n-a></a>Javor ED, Cochran EK, Musso C, <i> et al.</i>: Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. <i>Diabetes.</i> 2005; <b>54</b>(7): 1994–2002. <a target=xrefwindow id=d18048e2204 href="http://www.ncbi.nlm.nih.gov/pubmed/15983199">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2207 href="https://doi.org/10.2337/diabetes.54.7.1994">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d18048e2216 class=n-a></a>Mauvais-Jarvis F: Leptin-replacement therapy in lipodystrophy. <i>N Engl J Med.</i> 2002; <b>346</b>(25): 2008; author reply 2009-10. <a target=xrefwindow id=d18048e2224 href="http://www.ncbi.nlm.nih.gov/pubmed/12075066">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2227 href="https://doi.org/10.1056/NEJM200206203462515">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d18048e2236 class=n-a></a>Mulligan K, Khatami H, Schwarz JM, <i> et al.</i>: The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. <i>J Clin Endocrinol Metab.</i> 2009; <b>94</b>(4): 1137–44. <a target=xrefwindow id=d18048e2247 href="http://www.ncbi.nlm.nih.gov/pubmed/19174500">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2250 href="https://doi.org/10.1210/jc.2008-1588">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2254 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2682465">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d18048e2263 class=n-a></a>Wolfsdorf J, Sadeghi-Nejad A, Senior B: Leptin-replacement therapy in lipodystrophy. <i>N Engl J Med.</i> 2002; <b>346</b>(25): 2008–9; author reply 2009–10. <a target=xrefwindow id=d18048e2271 href="http://www.ncbi.nlm.nih.gov/pubmed/12078705">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2274 href="https://doi.org/10.1056/NEJM200206203462515">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d18048e2283 class=n-a></a>FDA: Myalept FDA US FOOD &amp; DRUG. 2014; 2019. </span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d18048e2292 class=n-a></a>Hall JE, do Carmo JM, da Silva AA, <i> et al.</i>: Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. <i>Circ Res.</i> 2015; <b>116</b>(6): 991–1006. <a target=xrefwindow id=d18048e2303 href="http://www.ncbi.nlm.nih.gov/pubmed/25767285">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2306 href="https://doi.org/10.1161/CIRCRESAHA.116.305697">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2310 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4363087">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d18048e2320 class=n-a></a>Faulkner JL, Belin de Chantemèle EJ: Sex Differences in Mechanisms of Hypertension Associated With Obesity. <i>Hypertension.</i> 2018; <b>71</b>(1): 15–21. <a target=xrefwindow id=d18048e2328 href="http://www.ncbi.nlm.nih.gov/pubmed/29133358">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2331 href="https://doi.org/10.1161/HYPERTENSIONAHA.117.09980">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2334 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5730468">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d18048e2343 class=n-a></a>Bhayana S, Siu VM, Joubert GI, <i> et al.</i>: Cardiomyopathy in congenital complete lipodystrophy. <i>Clin Genet.</i> 2002; <b>61</b>(4): 283–7. <a target=xrefwindow id=d18048e2354 href="http://www.ncbi.nlm.nih.gov/pubmed/12030893">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2357 href="https://doi.org/10.1034/j.1399-0004.2002.610407.x">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d18048e2366 class=n-a></a>Lupsa BC, Sachdev V, Lungu AO, <i> et al.</i>: Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment. <i>Medicine (Baltimore).</i> 2010; <b>89</b>(4): 245–50. <a target=xrefwindow id=d18048e2377 href="http://www.ncbi.nlm.nih.gov/pubmed/20616664">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2380 href="https://doi.org/10.1097/MD.0b013e3181e9442f">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2384 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3090142">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d18048e2393 class=n-a></a>Sanon VP, Handelsman Y, Pham SV, <i> et al.</i>: Cardiac Manifestations of Congenital Generalized Lipodystrophy. <i>Clin Diabetes.</i> 2016; <b>34</b>(4): 181–186. <a target=xrefwindow id=d18048e2404 href="http://www.ncbi.nlm.nih.gov/pubmed/27766009">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2407 href="https://doi.org/10.2337/cd16-0002">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5070584">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736719566"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e2420 class=n-a></a>Hussain I, Patni N, Garg A: Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease. <i>Pathology.</i> 2019; <b>51</b>(2): 202–212. <a target=xrefwindow id=d18048e2428 href="http://www.ncbi.nlm.nih.gov/pubmed/30595509">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2431 href="https://doi.org/10.1016/j.pathol.2018.11.004">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2434 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6402807">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736719566">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d18048e2448 class=n-a></a>Prieur X, Le May C, Magré J, <i> et al.</i>: Congenital lipodystrophies and dyslipidemias. <i>Curr Atheroscler Rep.</i> 2014; <b>16</b>(9): 437. <a target=xrefwindow id=d18048e2459 href="http://www.ncbi.nlm.nih.gov/pubmed/25047893">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2462 href="https://doi.org/10.1007/s11883-014-0437-x">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d18048e2472 class=n-a></a>Brown RJ, Meehan CA, Gorden P: Leptin Does Not Mediate Hypertension Associated With Human Obesity. <i>Cell.</i> 2015; <b>162</b>(3): 465–6. <a target=xrefwindow id=d18048e2480 href="http://www.ncbi.nlm.nih.gov/pubmed/26232214">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2483 href="https://doi.org/10.1016/j.cell.2015.07.007">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d18048e2492 class=n-a></a>Rêgo AG, Mesquita ET, Faria CA, <i> et al.</i>: [Cardiometabolic abnormalities in patients with Berardinelli-Seip syndrome]. <i>Arq Bras Cardiol.</i> 2010; <b>94</b>(1): 109–18. <a target=xrefwindow id=d18048e2503 href="http://www.ncbi.nlm.nih.gov/pubmed/20414534">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2506 href="https://doi.org/10.1590/s0066-782x2010000100017">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d18048e2515 class=n-a></a>Rochford JJ: Mouse models of lipodystrophy and their significance in understanding fat regulation. <i>Curr Top Dev Biol.</i> 2014; <b>109</b>: 53–96. <a target=xrefwindow id=d18048e2523 href="http://www.ncbi.nlm.nih.gov/pubmed/24947236">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2526 href="https://doi.org/10.1016/B978-0-12-397920-9.00005-6">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d18048e2535 class=n-a></a>Chen W, Chang B, Saha P, <i> et al.</i>: Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation. <i>Mol Cell Biol.</i> 2012; <b>32</b>(6): 1099–111. <a target=xrefwindow id=d18048e2546 href="http://www.ncbi.nlm.nih.gov/pubmed/22269949">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2549 href="https://doi.org/10.1128/MCB.06465-11">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2553 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3295006">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d18048e2562 class=n-a></a>Asterholm IW, Halberg N, Scherer PE: Mouse Models of Lipodystrophy Key reagents for the understanding of the metabolic syndrome. <i>Drug Discov Today Dis Models.</i> 2007; <b>4</b>(1): 17–24. <a target=xrefwindow id=d18048e2570 href="http://www.ncbi.nlm.nih.gov/pubmed/18193096">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2573 href="https://doi.org/10.1016/j.ddmod.2007.10.003">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2576 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2194626">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d18048e2585 class=n-a></a>Shimomura I, Hammer RE, Ikemoto S, <i> et al.</i>: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. <i>Nature.</i> 1999; <b>401</b>(6748): 73–6. <a target=xrefwindow id=d18048e2596 href="http://www.ncbi.nlm.nih.gov/pubmed/10485707">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2599 href="https://doi.org/10.1038/43448">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d18048e2609 class=n-a></a>Liu L, Jiang Q, Wang X, <i> et al.</i>: Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy. <i>Diabetes.</i> 2014; <b>63</b>(7): 2320–31. <a target=xrefwindow id=d18048e2620 href="http://www.ncbi.nlm.nih.gov/pubmed/24622797">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2623 href="https://doi.org/10.2337/db13-0729">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d18048e2632 class=n-a></a>Razani B, Combs TP, Wang XB, <i> et al.</i>: Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. <i>J Biol Chem.</i> 2002; <b>277</b>(10): 8635–47. <a target=xrefwindow id=d18048e2643 href="http://www.ncbi.nlm.nih.gov/pubmed/11739396">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2646 href="https://doi.org/10.1074/jbc.M110970200">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d18048e2655 class=n-a></a>Wang F, Mullican SE, DiSpirito JR, <i> et al.</i>: Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(46): 18656–61. <a target=xrefwindow id=d18048e2666 href="http://www.ncbi.nlm.nih.gov/pubmed/24167256">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2669 href="https://doi.org/10.1073/pnas.1314863110">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2673 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3831974">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d18048e2682 class=n-a></a>He W, Barak Y, Hevener A, <i> et al.</i>: Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. <i>Proc Natl Acad Sci U S A.</i> 2003; <b>100</b>(26): 15712–7. <a target=xrefwindow id=d18048e2693 href="http://www.ncbi.nlm.nih.gov/pubmed/14660788">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2696 href="https://doi.org/10.1073/pnas.2536828100">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2700 href="http://www.ncbi.nlm.nih.gov/pmc/articles/307633">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d18048e2709 class=n-a></a>Wu CH, Mohammadmoradi S, Thompson J, <i> et al.</i>: Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice. <i>Hypertension.</i> 2016; <b>68</b>(1): 213–9. <a target=xrefwindow id=d18048e2720 href="http://www.ncbi.nlm.nih.gov/pubmed/27185751">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2723 href="https://doi.org/10.1161/HYPERTENSIONAHA.115.06954">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2727 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4900901">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d18048e2736 class=n-a></a>Shimomura I, Hammer RE, Richardson JA, <i> et al.</i>: Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy. <i>Genes Dev.</i> 1998; <b>12</b>(20): 3182–94. <a target=xrefwindow id=d18048e2747 href="http://www.ncbi.nlm.nih.gov/pubmed/9784493">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2750 href="https://doi.org/10.1101/gad.12.20.3182">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2754 href="http://www.ncbi.nlm.nih.gov/pmc/articles/317215">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d18048e2764 class=n-a></a>Moitra J, Mason MM, Olive M, <i> et al.</i>: Life without white fat: A transgenic mouse. <i>Genes Dev.</i> 1998; <b>12</b>(20): 3168–81. <a target=xrefwindow id=d18048e2775 href="http://www.ncbi.nlm.nih.gov/pubmed/9784492">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2778 href="https://doi.org/10.1101/gad.12.20.3168">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2782 href="http://www.ncbi.nlm.nih.gov/pmc/articles/317213">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735968897"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e2791 class=n-a></a>Zhou H, Lei X, Yan Y, <i> et al.</i>: Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy. <i>JCI Insight.</i> 2019; <b>5</b>: pii: 129781. <a target=xrefwindow id=d18048e2802 href="http://www.ncbi.nlm.nih.gov/pubmed/31185001">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2805 href="https://doi.org/10.1172/jci.insight.129781">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2809 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6675548">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735968897">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d18048e2822 class=n-a></a>Joubert M, Jagu B, Montaigne D, <i> et al.</i>: The SGLT2 inhibitor dapagliflozin prevents cardiomyopathy in a diabetic lipodystrophic mouse model. <i>Diabetes.</i> 2017; <b>9</b>(2): 171. <a target=xrefwindow id=d18048e2833 href="https://doi.org/10.1016/S1878-6480(17)30427-5">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d18048e2842 class=n-a></a>Barroso I, Gurnell M, Crowley VE, <i> et al.</i>: Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. <i>Nature.</i> 1999; <b>402</b>(6764): 880–3. <a target=xrefwindow id=d18048e2853 href="http://www.ncbi.nlm.nih.gov/pubmed/10622252">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2856 href="https://doi.org/10.1038/47254">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d18048e2865 class=n-a></a>Auclair M, Vigouroux C, Boccara F, <i> et al.</i>: Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system. <i>Arterioscler Thromb Vasc Biol.</i> 2013; <b>33</b>(4): 829–38. <a target=xrefwindow id=d18048e2876 href="http://www.ncbi.nlm.nih.gov/pubmed/23393388">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2879 href="https://doi.org/10.1161/ATVBAHA.112.300962">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1030491"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e2888 class=n-a></a>Boguslavsky RL, Stewart CL, Worman HJ: Nuclear lamin A inhibits adipocyte differentiation: Implications for Dunnigan-type familial partial lipodystrophy. <i>Hum Mol Genet.</i> 2006; <b>15</b>(4): 653–63. <a target=xrefwindow id=d18048e2896 href="http://www.ncbi.nlm.nih.gov/pubmed/16415042">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2899 href="https://doi.org/10.1093/hmg/ddi480">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1030491">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d18048e2913 class=n-a></a>Hegele RA, Leff T: Unbuckling lipodystrophy from insulin resistance and hypertension. <i>J Clin Invest.</i> 2004; <b>114</b>(2): 163–5. <a target=xrefwindow id=d18048e2921 href="http://www.ncbi.nlm.nih.gov/pubmed/15254581">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2924 href="https://doi.org/10.1172/JCI22382">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2927 href="http://www.ncbi.nlm.nih.gov/pmc/articles/449754">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d18048e2936 class=n-a></a>Fernández-Hernando C, Yu J, Suárez Y, <i> et al.</i>: Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. <i>Cell Metab.</i> 2009; <b>10</b>(1): 48–54. <a target=xrefwindow id=d18048e2947 href="http://www.ncbi.nlm.nih.gov/pubmed/19583953">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2950 href="https://doi.org/10.1016/j.cmet.2009.06.003">Publisher Full Text </a> | <a target=xrefwindow id=d18048e2954 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2735117">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1003013"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e2963 class=n-a></a>Drab M, Verkade P, Elger M, <i> et al.</i>: Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. <i>Science.</i> 2001; <b>293</b>(5539): 2449–52. <a target=xrefwindow id=d18048e2974 href="http://www.ncbi.nlm.nih.gov/pubmed/11498544">PubMed Abstract </a> | <a target=xrefwindow id=d18048e2977 href="https://doi.org/10.1126/science.1062688">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1003013">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d18048e2990 class=n-a></a>Razani B, Engelman JA, Wang XB, <i> et al.</i>: Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. <i>J Biol Chem.</i> 2001; <b>276</b>(41): 38121–38. <a target=xrefwindow id=d18048e3001 href="http://www.ncbi.nlm.nih.gov/pubmed/11457855">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3004 href="https://doi.org/10.1074/jbc.M105408200">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d18048e3013 class=n-a></a>Zhao YY, Liu Y, Stan RV, <i> et al.</i>: Defects in <i>caveolin</i>-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. <i>Proc Natl Acad Sci U S A.</i> 2002; <b>99</b>(17): 11375–80. <a target=xrefwindow id=d18048e3027 href="http://www.ncbi.nlm.nih.gov/pubmed/12177436">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3031 href="https://doi.org/10.1073/pnas.172360799">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3034 href="http://www.ncbi.nlm.nih.gov/pmc/articles/123264">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d18048e3043 class=n-a></a>Vogel P, Read R, Hansen G, <i> et al.</i>: Pathology of congenital generalized lipodystrophy in <i>Agpat</i>2-/- mice. <i>Vet Pathol.</i> 2011; <b>48</b>(3): 642–54. <a target=xrefwindow id=d18048e3057 href="http://www.ncbi.nlm.nih.gov/pubmed/21051554">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3061 href="https://doi.org/10.1177/0300985810383870">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d18048e3071 class=n-a></a>Cautivo KM, Lizama CO, Tapia PJ, <i> et al.</i>: AGPAT2 is essential for postnatal development and maintenance of white and brown adipose tissue. <i>Mol Metab.</i> 2016; <b>5</b>(7): 491–505. <a target=xrefwindow id=d18048e3082 href="http://www.ncbi.nlm.nih.gov/pubmed/27408775">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3085 href="https://doi.org/10.1016/j.molmet.2016.05.004">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3089 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4921804">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d18048e3098 class=n-a></a>Fernández-Galilea M, Tapia P, Cautivo K, <i> et al.</i>: AGPAT2 deficiency impairs adipogenic differentiation in primary cultured preadipocytes in a non-autophagy or apoptosis dependent mechanism. <i>Biochem Biophys Res Commun.</i> 2015; <b>467</b>(1): 39–45. <a target=xrefwindow id=d18048e3109 href="http://www.ncbi.nlm.nih.gov/pubmed/26417690">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3112 href="https://doi.org/10.1016/j.bbrc.2015.09.128">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d18048e3121 class=n-a></a>Bruder-Nascimento T, Faulkner JL, Haigh S, <i> et al.</i>: Leptin restores endothelial function via endothelial PPARg- Nox1 mediated mechanisms in a mouse model of congenital generalized lipodystrophy. <i>Hypertension.</i> In press. </span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d18048e3136 class=n-a></a>Nguyen G, Muller DN: The biology of the (pro)renin receptor. <i>J Am Soc Nephrol.</i> 2010; <b>21</b>(1): 18–23. <a target=xrefwindow id=d18048e3144 href="http://www.ncbi.nlm.nih.gov/pubmed/19917780">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3147 href="https://doi.org/10.1681/ASN.2009030300">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d18048e3156 class=n-a></a>Takemori K, Gao YJ, Ding L, <i> et al.</i>: Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. <i>Hypertension.</i> 2007; <b>49</b>(2): 365–72. <a target=xrefwindow id=d18048e3167 href="http://www.ncbi.nlm.nih.gov/pubmed/17200435">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3170 href="https://doi.org/10.1161/01.HYP.0000255576.16089.b9">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d18048e3179 class=n-a></a>Kim JK, Gavrilova O, Chen Y, <i> et al.</i>: Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. <i>J Biol Chem.</i> 2000; <b>275</b>(12): 8456–60. <a target=xrefwindow id=d18048e3190 href="http://www.ncbi.nlm.nih.gov/pubmed/10722680">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3193 href="https://doi.org/10.1074/jbc.275.12.8456">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d18048e3203 class=n-a></a>Pavlides S, Gutierrez-Pajares JL, Danilo C, <i> et al.</i>: Atherosclerosis, caveolae and caveolin-1. <i>Adv Exp Med Biol.</i> 2012; <b>729</b>: 127–44. <a target=xrefwindow id=d18048e3214 href="http://www.ncbi.nlm.nih.gov/pubmed/22411318">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3217 href="https://doi.org/10.1007/978-1-4614-1222-9_9">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d18048e3226 class=n-a></a>Murata T, Lin MI, Huang Y, <i> et al.</i>: Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. <i>J Exp Med.</i> 2007; <b>204</b>(10): 2373–82. <a target=xrefwindow id=d18048e3237 href="http://www.ncbi.nlm.nih.gov/pubmed/17893196">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3240 href="https://doi.org/10.1084/jem.20062340">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3244 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2118452">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d18048e3253 class=n-a></a>Wang M, Gao M, Liao J, <i> et al.</i>: Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice. <i>Biochim Biophys Acta.</i> 2016; <b>1861</b>(1): 410–8. <a target=xrefwindow id=d18048e3264 href="http://www.ncbi.nlm.nih.gov/pubmed/26921684">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3267 href="https://doi.org/10.1016/j.bbalip.2016.02.018">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d18048e3276 class=n-a></a>Cipriani S, Francisci D, Mencarelli A, <i> et al.</i>: Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. <i>Circulation.</i> 2013; <b>127</b>(21): 2114–24. <a target=xrefwindow id=d18048e3287 href="http://www.ncbi.nlm.nih.gov/pubmed/23633271">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3290 href="https://doi.org/10.1161/CIRCULATIONAHA.113.001278">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d18048e3299 class=n-a></a>Jiang B, Khandelwal AR, Rogers LK, <i> et al.</i>: Antiretrovirals induce endothelial dysfunction <i>via</i> an oxidant-dependent pathway and promote neointimal hyperplasia. <i>Toxicol Sci.</i> 2010; <b>117</b>(2): 524–36. <a target=xrefwindow id=d18048e3313 href="http://www.ncbi.nlm.nih.gov/pubmed/20621964">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3317 href="https://doi.org/10.1093/toxsci/kfq213">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3320 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2940409">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d18048e3329 class=n-a></a>Jones KL, Maguire JJ, Davenport AP: Chemokine receptor CCR5: From AIDS to atherosclerosis. <i>Br J Pharmacol.</i> 2011; <b>162</b>(7): 1453–69. <a target=xrefwindow id=d18048e3337 href="http://www.ncbi.nlm.nih.gov/pubmed/21133894">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3340 href="https://doi.org/10.1111/j.1476-5381.2010.01147.x">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3343 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3057285">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d18048e3353 class=n-a></a>Stein JH, Klein MA, Bellehumeur JL, <i> et al.</i>: Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. <i>Circulation.</i> 2001; <b>104</b>(3): 257–62. <a target=xrefwindow id=d18048e3364 href="http://www.ncbi.nlm.nih.gov/pubmed/11457741">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3367 href="https://doi.org/10.1161/01.cir.104.3.257">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d18048e3376 class=n-a></a>Tawakol A, Lo J, Zanni MV, <i> et al.</i>: Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients. <i>J Acquir Immune Defic Syndr.</i> 2014; <b>66</b>(2): 164–71. <a target=xrefwindow id=d18048e3387 href="http://www.ncbi.nlm.nih.gov/pubmed/24828267">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3390 href="https://doi.org/10.1097/QAI.0000000000000138">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3394 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4023912">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d18048e3403 class=n-a></a>Lamounier-Zepter V, Bornstein SR, Kunes J, <i> et al.</i>: Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice. <i>Mol Cell Endocrinol.</i> 2008; <b>280</b>(1–2): 39–46. <a target=xrefwindow id=d18048e3414 href="http://www.ncbi.nlm.nih.gov/pubmed/18045774">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3417 href="https://doi.org/10.1016/j.mce.2007.09.012">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734635709"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e3426 class=n-a></a>Gatineau E, Cohn DM, Poglitsch M, <i> et al.</i>: Losartan prevents the elevation of blood pressure in adipose-PRR deficient female mice while elevated circulating sPRR activates the renin-angiotensin system. <i>Am J Physiol Heart Circ Physiol.</i> 2019; <b>316</b>(3): H506–H515. <a target=xrefwindow id=d18048e3437 href="http://www.ncbi.nlm.nih.gov/pubmed/30550352">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3440 href="https://doi.org/10.1152/ajpheart.00473.2018">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3444 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6734055">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734635709">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d18048e3458 class=n-a></a>Belin de Chantemèle EJ: Sex Differences in Leptin Control of Cardiovascular Function in Health and Metabolic Diseases. <i>Adv Exp Med Biol.</i> 2017; <b>1043</b>: 87–111. <a target=xrefwindow id=d18048e3466 href="http://www.ncbi.nlm.nih.gov/pubmed/29224092">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3469 href="https://doi.org/10.1007/978-3-319-70178-3_6">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11570956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e3478 class=n-a></a>Belin de Chantemèle EJ, Mintz JD, Rainey WE, <i> et al.</i>: Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. <i>Hypertension.</i> 2011; <b>58</b>(2): 271–9. <a target=xrefwindow id=d18048e3489 href="http://www.ncbi.nlm.nih.gov/pubmed/21690486">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3492 href="https://doi.org/10.1161/HYPERTENSIONAHA.110.168427">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3141100">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11570956">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d18048e3511 class=n-a></a>Belin de Chantemèle EJ, Muta K, Mintz J, <i> et al.</i>: Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function. <i>Circulation.</i> 2009; <b>120</b>(9): 753–63. <a target=xrefwindow id=d18048e3522 href="http://www.ncbi.nlm.nih.gov/pubmed/19687357">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3525 href="https://doi.org/10.1161/CIRCULATIONAHA.109.853077">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2736363">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d18048e3538 class=n-a></a>Bruder-Nascimento T, Butler BR, Herren DJ, <i> et al.</i>: Deletion of protein tyrosine phosphatase 1b in proopiomelanocortin neurons reduces neurogenic control of blood pressure and protects mice from leptin- and sympatho-mediated hypertension. <i>Pharmacol Res.</i> 2015; <b>102</b>: 235–44. <a target=xrefwindow id=d18048e3549 href="http://www.ncbi.nlm.nih.gov/pubmed/26523876">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3552 href="https://doi.org/10.1016/j.phrs.2015.10.012">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d18048e3561 class=n-a></a>Mark AL, Shaffer RA, Correia ML, <i> et al.</i>: Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. <i>J Hypertens.</i> 1999; <b>17</b>(12 Pt 2): 1949–53. <a target=xrefwindow id=d18048e3572 href="http://www.ncbi.nlm.nih.gov/pubmed/10703894">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3575 href="https://doi.org/10.1097/00004872-199917121-00026">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725782690"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e3584 class=n-a></a>Huby AC, Antonova G, Groenendyk J, <i> et al.</i>: Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis. <i>Circulation.</i> 2015; <b>132</b>(22): 2134–45. <a target=xrefwindow id=d18048e3595 href="http://www.ncbi.nlm.nih.gov/pubmed/26362633">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3598 href="https://doi.org/10.1161/CIRCULATIONAHA.115.018226">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725782690">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d18048e3612 class=n-a></a>Huby AC, Otvos L, Belin de Chantemèle EJ: Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice. <i>Hypertension.</i> 2016; <b>67</b>(5): 1020–8. <a target=xrefwindow id=d18048e3620 href="http://www.ncbi.nlm.nih.gov/pubmed/26953321">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3623 href="https://doi.org/10.1161/HYPERTENSIONAHA.115.06642">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3626 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5088432">Free Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d18048e3635 class=n-a></a>Saad MF, Rewers M, Selby J, <i> et al.</i>: Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. <i>Hypertension.</i> 2004; <b>43</b>(6): 1324–31. <a target=xrefwindow id=d18048e3646 href="http://www.ncbi.nlm.nih.gov/pubmed/15123571">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3649 href="https://doi.org/10.1161/01.HYP.0000128019.19363.f9">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d18048e3659 class=n-a></a>Arnlöv J, Pencina MJ, Nam BH, <i> et al.</i>: Relations of insulin sensitivity to longitudinal blood pressure tracking: Variations with baseline age, body mass index, and blood pressure. <i>Circulation.</i> 2005; <b>112</b>(12): 1719–27. <a target=xrefwindow id=d18048e3670 href="http://www.ncbi.nlm.nih.gov/pubmed/16157770">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3673 href="https://doi.org/10.1161/CIRCULATIONAHA.105.535039">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d18048e3682 class=n-a></a>Rahmouni K, Haynes WG, Mark AL: Cardiovascular and sympathetic effects of leptin. <i>Curr Hypertens Rep.</i> 2002; <b>4</b>(2): 119–25. <a target=xrefwindow id=d18048e3690 href="http://www.ncbi.nlm.nih.gov/pubmed/11884267">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3693 href="https://doi.org/10.1007/s11906-002-0036-z">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d18048e3702 class=n-a></a>Vecchione C, Maffei A, Colella S, <i> et al.</i>: Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. <i>Diabetes.</i> 2002; <b>51</b>(1): 168–73. <a target=xrefwindow id=d18048e3713 href="http://www.ncbi.nlm.nih.gov/pubmed/11756337">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3716 href="https://doi.org/10.2337/diabetes.51.1.168">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d18048e3725 class=n-a></a>Benkhoff S, Loot AE, Pierson I, <i> et al.</i>: Leptin potentiates endothelium-dependent relaxation by Inducing endothelial expression of neuronal NO synthase. <i>Arterioscler Thromb Vasc Biol.</i> 2012; <b>32</b>(7): 1605–12. <a target=xrefwindow id=d18048e3736 href="http://www.ncbi.nlm.nih.gov/pubmed/22580898">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3739 href="https://doi.org/10.1161/ATVBAHA.112.251140">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727808167"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e3748 class=n-a></a>Hubert A, Bochenek ML, Schütz E, <i> et al.</i>: Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice. <i>Arterioscler Thromb Vasc Biol.</i> 2017; <b>37</b>(9): 1683–97. <a target=xrefwindow id=d18048e3759 href="http://www.ncbi.nlm.nih.gov/pubmed/28705795">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3762 href="https://doi.org/10.1161/ATVBAHA.117.309798">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727808167">F1000 Recommendation</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d18048e3776 class=n-a></a>Rajapurohitam V, Gan XT, Kirshenbaum LA, <i> et al.</i>: The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. <i>Circ Res.</i> 2003; <b>93</b>(4): 277–9. <a target=xrefwindow id=d18048e3787 href="http://www.ncbi.nlm.nih.gov/pubmed/12893740">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3790 href="https://doi.org/10.1161/01.RES.0000089255.37804.72">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d18048e3800 class=n-a></a>Paolisso G, Tagliamonte MR, Galderisi M, <i> et al.</i>: Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry. <i>Am J Hypertens.</i> 2001; <b>14</b>(2): 114–20. <a target=xrefwindow id=d18048e3811 href="http://www.ncbi.nlm.nih.gov/pubmed/11243301">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3814 href="https://doi.org/10.1016/s0895-7061(00)01241-3">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d18048e3823 class=n-a></a>Hall ME, Harmancey R, Stec DE: Lean heart: Role of leptin in cardiac hypertrophy and metabolism. <i>World J Cardiol.</i> 2015; <b>7</b>(9): 511–24. <a target=xrefwindow id=d18048e3831 href="http://www.ncbi.nlm.nih.gov/pubmed/26413228">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3834 href="https://doi.org/10.4330/wjc.v7.i9.511">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3837 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4577678">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d18048e3846 class=n-a></a>Stern JH, Rutkowski JM, Scherer PE: Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. <i>Cell Metab.</i> 2016; <b>23</b>(5): 770–84. <a target=xrefwindow id=d18048e3854 href="http://www.ncbi.nlm.nih.gov/pubmed/27166942">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3857 href="https://doi.org/10.1016/j.cmet.2016.04.011">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3860 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4864949">Free Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726850898"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18048e3869 class=n-a></a>Vatier C, Arnaud L, Prieur X, <i> et al.</i>: One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes. <i>Diabetes Metab.</i> 2017; <b>43</b>(3): 275–279. <a target=xrefwindow id=d18048e3880 href="http://www.ncbi.nlm.nih.gov/pubmed/27692500">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3883 href="https://doi.org/10.1016/j.diabet.2016.08.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726850898">F1000 Recommendation</a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d18048e3896 class=n-a></a>Gainsford T, Willson TA, Metcalf D, <i> et al.</i>: Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. <i>Proc Natl Acad Sci U S A.</i> 1996; <b>93</b>(25): 14564–8. <a target=xrefwindow id=d18048e3907 href="http://www.ncbi.nlm.nih.gov/pubmed/8962092">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3910 href="https://doi.org/10.1073/pnas.93.25.14564">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3914 href="http://www.ncbi.nlm.nih.gov/pmc/articles/26173">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d18048e3923 class=n-a></a>Chan JL, Koda J, Heilig JS, <i> et al.</i>: Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy. <i>Clin Endocrinol (Oxf).</i> 2016; <b>85</b>(1): 137–49. <a target=xrefwindow id=d18048e3934 href="http://www.ncbi.nlm.nih.gov/pubmed/26589105">PubMed Abstract </a> | <a target=xrefwindow id=d18048e3937 href="https://doi.org/10.1111/cen.12980">Publisher Full Text </a> | <a target=xrefwindow id=d18048e3941 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4875885">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d18048e3951 class=n-a></a>Ltd WAP: Myalepta (metreleptin) 3, 5.8 and 11.3 mg powder for solution for injection: EU summary of product characteristics. Windsor: Aegerion Pharmaceuticals Ltd. 2018. <a target=xrefwindow id=d18048e3953 href="https://www.ema.europa.eu/en/documents/product-information/myalepta-epar-product-information_en.pdf">Reference Source</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 16 Oct 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-1756&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-1756&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USA<br/> <sup>2</sup> Department of Pediatrics, Division of Endocrinology, University of Pittsburgh, Pittsburgh, PA, USA<br/> <sup>3</sup> Department of Medicine, Section of Cardiology, Medical College of Georgia at Augusta University, Augusta, GA, USA<br/> <p> <div class=margin-bottom> Thiago Bruder-Nascimento <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Taylor C. Kress <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Eric J. Belin de Chantemele <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-1756/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 16 Oct 2019, 8:1756 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.20150.1">https://doi.org/10.12688/f1000research.20150.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Bruder-Nascimento T <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=22135 data-id=20150 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20150.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-1756/v1/pdf?article_uuid=fcda0961-7e39-40e3-80ca-6ac8c2c2e96f" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.20150.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Bruder-Nascimento T, Kress TC and Belin de Chantemele EJ. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function [version 1; peer review: 3 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1756 (<a href="https://doi.org/10.12688/f1000research.20150.1" target=_blank>https://doi.org/10.12688/f1000research.20150.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=20150 id=mobile-track-article-signin-20150 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20150?target=/articles/8-1756"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22135 /> <input name=articleId type=hidden value=20150 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Jussara do Carmo</strong>, Department of Physiology and Biophysics, University of Mississippi Medical Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Frederique Yiannikouris</strong>, Department of Pharmacology and Nutritional Sciences, University of Kentucky, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Xavier Prieur</strong>, L'Institut du Thorax, INSERM, CNRS, Université de Nantes, France </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 16 Oct 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-1756&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-1756&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=58206-54856></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=58205-54858></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=58204-54857></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-1756/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>16 Oct 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jussara do Carmo</strong>, Department of Physiology and Biophysics, University of Mississippi Medical Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Frederique Yiannikouris</strong>, Department of Pharmacology and Nutritional Sciences, University of Kentucky, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Xavier Prieur</strong>, L'Institut du Thorax, INSERM, CNRS, Université de Nantes, France </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-1756&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-1756/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding lipodystrophy:...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-1756/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-1756/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-1756/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Bruder-Nascimento T et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-1756/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-1756",
            templates : {
                twitter : "Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated.... Bruder-Nascimento T et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-1756/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/20150/22135")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "22135");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "54856": 0,
                           "54857": 1,
                           "54858": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "aff7ddab-f869-420e-a442-05e520307073";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1756.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1756.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1756.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-1756.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-1756.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>